{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:14:49Z","timestamp":1790788489640,"version":"4.1.0"},"reference-count":38,"publisher":"Society of Nuclear Medicine","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.2967\/jnumed.118.216747","type":"journal-article","created":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T14:06:59Z","timestamp":1538057219000},"page":"683-690","source":"Crossref","is-referenced-by-count":89,"title":["<sup>18<\/sup>\n                    F-JNJ-64413739, a Novel PET Ligand for the P2X7 Ion Channel: Radiation Dosimetry, Kinetic Modeling, Test-Retest Variability, and Occupancy of the P2X7 Antagonist JNJ-54175446"],"prefix":"10.2967","volume":"60","author":[{"given":"Michel","family":"Koole","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark E.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Hijzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulien","family":"Ravenstijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Vandermeulen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donatienne","family":"Van Weehaeghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Serdons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofie","family":"Celen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Bormans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Ceusters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Van Nueten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartmuth","family":"Kolb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"de Hoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koen","family":"Van Laere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2018,9,27]]},"reference":[{"key":"2021051712131578000_60.5.683.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2014.08.002"},{"key":"2021051712131578000_60.5.683.2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M006781200"},{"key":"2021051712131578000_60.5.683.3","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1021\/acschemneuro.5b00303","article-title":"Novel phenyl-substituted 5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazine P2X7 antagonists with robust target engagement in rat brain","volume":"7","author":"Chrovian","year":"2016","journal-title":"ACS Chem Neurosci."},{"key":"2021051712131578000_60.5.683.4","doi-asserted-by":"publisher","DOI":"10.1002\/glia.22707"},{"key":"2021051712131578000_60.5.683.5","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.neuropharm.2013.05.032","article-title":"P2X7 receptor activation regulates microglial cell death during oxygen-glucose deprivation","volume":"73","author":"Eyo","year":"2013","journal-title":"Neuropharmacology."},{"key":"2021051712131578000_60.5.683.6","doi-asserted-by":"crossref","first-page":"38499","DOI":"10.1038\/srep38499","article-title":"Involvement of P2X7 receptor in neuronal degeneration triggered by traumatic injury","volume":"6","author":"Nadal-Nicol\u00e1s","year":"2016","journal-title":"Sci Rep."},{"key":"2021051712131578000_60.5.683.7","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.4009-15.2016"},{"key":"2021051712131578000_60.5.683.8","doi-asserted-by":"publisher","DOI":"10.1007\/s00005-010-0069-y"},{"key":"2021051712131578000_60.5.683.9","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1203262"},{"key":"2021051712131578000_60.5.683.10","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.017038"},{"key":"2021051712131578000_60.5.683.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2011.09.040"},{"key":"2021051712131578000_60.5.683.12","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1016\/j.neurobiolaging.2015.03.015","article-title":"P2X7 receptor is critical in alpha-synuclein\u2013mediated microglial NADPH oxidase activation","volume":"36","author":"Jiang","year":"2015","journal-title":"Neurobiol Aging."},{"key":"2021051712131578000_60.5.683.13","doi-asserted-by":"publisher","DOI":"10.1096\/fj.08-122275"},{"key":"2021051712131578000_60.5.683.14","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2015.00258"},{"key":"2021051712131578000_60.5.683.15","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.biopsych.2015.11.026","article-title":"Psychological stress activates the inflammasome via release of adenosine triphosphate and stimulation of the purinergic type 2X7 receptor","volume":"80","author":"Iwata","year":"2016","journal-title":"Biol Psychiatry."},{"key":"2021051712131578000_60.5.683.16","doi-asserted-by":"publisher","DOI":"10.1002\/glia.23001"},{"key":"2021051712131578000_60.5.683.17","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.116.181354"},{"key":"2021051712131578000_60.5.683.18","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.169995"},{"key":"2021051712131578000_60.5.683.19","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13550-017-0275-2","article-title":"Design, synthesis and evaluation in an LPS rodent model of neuroinflammation of a novel 18F-labelled PET tracer targeting P2X7","volume":"7","author":"Fantoni","year":"2017","journal-title":"EJNMMI Res."},{"key":"2021051712131578000_60.5.683.20","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejphar.2017.12.006","article-title":"Synthesis and in vitro characterization of a P2X7 radioligand [123I]TZ6019 and its response to neuroinflammation in a mouse model of Alzheimer disease","volume":"820","author":"Jin","year":"2018","journal-title":"Eur J Pharmacol."},{"key":"2021051712131578000_60.5.683.21","doi-asserted-by":"crossref","first-page":"6580","DOI":"10.1038\/s41598-018-24814-0","article-title":"Identification of the allosteric P2X7 receptor antagonist [11C]SMW139 as a PET tracer of microglial activation","volume":"8","author":"Janssen","year":"2018","journal-title":"Sci Rep."},{"key":"2021051712131578000_60.5.683.22","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1016\/j.biopsych.2017.02.411","article-title":"Development and preclinical evaluation of [18F]JNJ-64413739 as a PET radioligand for P2X7 receptors","volume":"81","author":"Kolb","year":"2017","journal-title":"Biol Psychiatry."},{"key":"2021051712131578000_60.5.683.23","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1021\/acs.jmedchem.7b01279","article-title":"A dipolar cycloaddition reaction to access 6-methyl-4,5,6,7-tetrahydro-1H-[1,2,3]triazolo[4,5-c]pyridines enables the discovery synthesis and preclinical profiling of a P2X7 antagonist clinical candidate","volume":"61","author":"Chrovian","year":"2018","journal-title":"J Med Chem."},{"key":"2021051712131578000_60.5.683.24","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.1021\/acs.jmedchem.7b00408","article-title":"4-Methyl-6,7-dihydro-4H-triazolo[4,5-c]pyridine-based P2X7 receptor antagonists: optimization of pharmacokinetic properties leading to the identification of a clinical candidate","volume":"60","author":"Letavic","year":"2017","journal-title":"J Med Chem."},{"key":"2021051712131578000_60.5.683.25","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1177\/0269881118800067","article-title":"Clinical pharmacokinetics, pharmacodynamics, safety, and tolerability of JNJ-54175446, a brain permeable P2X7 antagonist, in a randomised single-ascending dose study in healthy participants","volume":"32","author":"Timmers","year":"2018","journal-title":"J Psychopharmacol."},{"key":"2021051712131578000_60.5.683.26","first-page":"1023","article-title":"OLINDA\/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine","volume":"46","author":"Stabin","year":"2005","journal-title":"J Nucl Med."},{"key":"2021051712131578000_60.5.683.27","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/BF00175858","article-title":"Effective dose from radiopharmaceuticals","volume":"19","author":"Johansson","year":"1992","journal-title":"Eur J Nucl Med."},{"key":"2021051712131578000_60.5.683.28","doi-asserted-by":"publisher","DOI":"10.1038\/jcbfm.1990.127"},{"key":"2021051712131578000_60.5.683.29","doi-asserted-by":"crossref","unstructured":"Kolb H Barret O Bhattacharya A . Preclinical evaluation and non-human primate receptor occupancy study of 18F-JNJ-64413739, a novel PET radioligand for P2X7 receptors. J Nucl Med. February 7, 2019 [Epub ahead of print].","DOI":"10.2967\/jnumed.118.212696"},{"key":"2021051712131578000_60.5.683.30","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-013-2512-x"},{"key":"2021051712131578000_60.5.683.31","doi-asserted-by":"publisher","DOI":"10.1002\/glia.22674"},{"key":"2021051712131578000_60.5.683.32","doi-asserted-by":"publisher","DOI":"10.1002\/glia.20649"},{"key":"2021051712131578000_60.5.683.33","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-015-3149-8"},{"key":"2021051712131578000_60.5.683.34","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/2191-219X-2-15","article-title":"Kinetic analysis and test-retest variability of the radioligand 11C-(R)-PK11195 binding to TSPO in the human brain: a PET study in control subjects","volume":"23","author":"Ju\u010daite","year":"2012","journal-title":"EJNMMI Res"},{"key":"2021051712131578000_60.5.683.35","doi-asserted-by":"publisher","DOI":"10.1080\/00048670701399994"},{"key":"2021051712131578000_60.5.683.36","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.3487-16.2017"},{"key":"2021051712131578000_60.5.683.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2009.10.005"},{"key":"2021051712131578000_60.5.683.38","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/5584_2017_59","article-title":"The P2X7 receptor","volume":"1051","author":"Sluyter","year":"2017","journal-title":"Adv Exp Med Biol."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.118.216747","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T16:38:24Z","timestamp":1621269504000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.118.216747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,27]]},"references-count":38,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2019,5,1]]},"published-print":{"date-parts":[[2019,5]]}},"alternative-id":["10.2967\/jnumed.118.216747"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.118.216747","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,27]]}}}